CSF Biomarkers in Huntington's Disease
Author Information
Author(s): Huang Yen-Chu, Wu Yih-Ru, Tseng Mu-Yun, Chen Yi-Chun, Hsieh Sen-Yung, Chen Chiung-Mei
Primary Institution: Chang Gung Memorial Hospital, Chang-Gung University College of Medicine
Hypothesis
Increased levels of prothrombin, apolipoprotein A-IV, and haptoglobin in cerebrospinal fluid (CSF) may serve as potential biomarkers for Huntington's disease.
Conclusion
The study found that prothrombin, apolipoprotein A-IV, and haptoglobin levels are significantly elevated in the CSF of Huntington's disease patients compared to controls.
Supporting Evidence
- Prothrombin levels were found to be 1.66-fold higher in HD patients compared to controls.
- Apolipoprotein A-IV levels were 1.67-fold increased in HD patients.
- Haptoglobin levels were 1.96-fold higher in HD patients compared to controls.
- The CSF prothrombin/Alb ratio significantly correlated with disease severity.
Takeaway
This study looked at the fluid around the brain of people with Huntington's disease and found that certain proteins are higher than in healthy people, which might help doctors understand the disease better.
Methodology
The study used two-dimensional electrophoresis and mass spectrometry to analyze CSF samples from Huntington's disease patients and controls.
Potential Biases
Potential confounding variables due to the medications taken by patients.
Limitations
The study had a small sample size and included patients on various medications, which could confound the results.
Participant Demographics
9 Huntington's disease patients (5 males, 4 females) and 18 controls (7 males, 11 females).
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website